Technology · Biotechnology R&D expenditure
Papua New Guinea's expenditure on biotechnology research and development in 2026 was 5 $. The country ranks 112 out of 197 globally. The absence of a domestic research base, specialized university centers, and extremely limited state funding for science prevent this field from developing. The country's priorities remain fundamental healthcare issues (malaria, tuberculosis) and agriculture, which are addressed mainly through foreign grants.
Data for 2026 · unit: $
Position
#112 / 197
Papua New Guinea world ranking
Country position on the scale from last to first place for this indicator.
PG
#112
#197#1
Trend
Change over time
Change in indicator over the available period.
0
1990
1
2000
1
2010
3
2020
5
2025
5
2026
Values — $
Comparison
Top countries by Biotechnology R&D expenditure
Where Papua New Guinea stands in the world ranking.
1
CNChina
30 B
1
USUSA
30 B
3
JPJapan
25 B
4
MXMexico
1 B
4
BRBrazil
1 B
6
CACanada
800 M
6
DEGermany
800 M
8
ESSpain
650 M
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Biotechnology R&D expenditure in Papua New Guinea — how much?
Based on 2026 data — 5 $. This is rank #112 out of 197 countries.
What is Papua New Guinea's rank by Biotechnology R&D expenditure?
Papua New Guinea ranks #112 out of 197 countries in the world ranking by «Biotechnology R&D expenditure».
How has Biotechnology R&D expenditure changed in Papua New Guinea?
Over the available period the indicator changed from 0 to 5 $.